News

February 2, 2017

Light Therapy for Mesothelioma Patients Improved With Infrared Tracking Device

Scientists have improved the way light-based therapy is used on mesothelioma patients following surgery. Using a laser, the photodynamic therapy (PDT) kills off cancer cells that remain after surgery. Mesothelioma treatment ... Read more

February 2, 2017February 2, 2017

Australian Mesothelioma Death Rates Higher Among Some Immigrant Groups

News

People who migrated to Australia from the United Kingdom, Ireland, Italy, and Germany had significantly higher mesothelioma death rates between 1981 and 2012 than those born in Australia, a study ... Read more

February 1, 2017February 1, 2017

Non-coding RNA Could Lead to Treatment for Aggressive Mesothelioma, Study Says

News

A small non-coding RNA molecule, miR-34a, could become the centerpiece of a therapy to treat diffuse malignant peritoneal mesothelioma (DMPM), a rare subtype of malignant mesothelioma, a study indicates. The miR-34a ... Read more

January 31, 2017

Various Mesothelin-targeting Treatments for Mesothelioma Are in Clinical Trials

News

Several antibodies that bind to mesothelin, intended for the treatment of malignant mesothelioma and other cancers, are in various stages of development. Because the antibody-based drugs have different properties, clinical ... Read more

January 30, 2017

Evidence Supporting Benefit of Second-line Treatment for Mesothelioma Weak, Clinical Trials Needed

News

There is no clear evidence supporting the benefits of second-line active treatments for patients with malignant pleural mesothelioma (MPM) whose first line of treatment failed. This is according to an ... Read more

January 27, 2017

New Mesothelin-targeting Combo Shows Promise Against Cancer Cells in Mice Studies

News

An antibody and drug combination by Bayer that targets the molecule mesothelin was found to have potent anti-cancer effects on lab-grown cells and animal models of malignant mesothelioma, according to a ... Read more

January 26, 2017

Levels of Fibulin-3 Protein Could Help Diagnose Malignant Mesothelioma, Study Suggests

News

High levels of the protein fibulin-3 in the blood or the pleural effusion — the fluid that often accumulates in the space between the lung and chest wall of patients ... Read more

January 25, 2017

Therapy Restricting Growth of Blood Vessels Failed in Mesothelioma Clinical Trial

News

An investigational cancer drug that restricts the growth of new blood vessels failed to improve disease in a Phase 2 clinical trial in patients with malignant pleural mesothelioma who progressed after ... Read more

January 24, 2017

Removing DNA Modifications in Cancer Cells May Help Decrease Treatment Resistance in Mesothelioma

News

Cancer cells often exhibit changes in DNA, called epigenetic modifications, that help tumors progress and resist therapies. In malignant mesothelioma, removing those epigenetic modifications could be key to decreasing treatment ... Read more

January 23, 2017

Mayo Clinic Expert Stands By Checkpoint Immunotherapy’s Potential for Treating Pleural Mesothelioma

News

Many scientists may have lost their initial high hopes for checkpoint immunities in treating malignant pleural mesothelioma (MPM), but Aaron S. Mansfield, MD, at the Mayo Clinic remains convinced immunotherapy will ... Read more